- Home
- RVNC vs PFN Comparison
RVNC vs PFN Comparison
Compare RVNC & PFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- PFN
- Stock Information
- Founded
- RVNC 1999
- PFN 2004
- Country
- RVNC United States
- PFN United States
- Employees
- RVNC N/A
- PFN N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- PFN Finance/Investors Services
- Sector
- RVNC Health Care
- PFN Finance
- Exchange
- RVNC Nasdaq
- PFN Nasdaq
- Market Cap
- RVNC 599.6M
- PFN 661.3M
- IPO Year
- RVNC 2014
- PFN N/A
- Fundamental
- Price
- RVNC $5.78
- PFN $7.53
- Analyst Decision
- RVNC Buy
- PFN
- Analyst Count
- RVNC 10
- PFN 0
- Target Price
- RVNC $10.86
- PFN N/A
- AVG Volume (30 Days)
- RVNC 1.6M
- PFN 331.7K
- Earning Date
- RVNC 11-19-2024
- PFN 01-01-0001
- Dividend Yield
- RVNC N/A
- PFN 11.66%
- EPS Growth
- RVNC N/A
- PFN N/A
- EPS
- RVNC N/A
- PFN N/A
- Revenue
- RVNC $251,178,000.00
- PFN N/A
- Revenue This Year
- RVNC $20.36
- PFN N/A
- Revenue Next Year
- RVNC $31.66
- PFN N/A
- P/E Ratio
- RVNC N/A
- PFN N/A
- Revenue Growth
- RVNC 40.23
- PFN N/A
- 52 Week Low
- RVNC $2.30
- PFN $5.94
- 52 Week High
- RVNC $9.75
- PFN $7.58
- Technical
- Relative Strength Index (RSI)
- RVNC 56.47
- PFN 48.69
- Support Level
- RVNC $5.67
- PFN $7.47
- Resistance Level
- RVNC $5.97
- PFN $7.56
- Average True Range (ATR)
- RVNC 0.19
- PFN 0.06
- MACD
- RVNC 0.06
- PFN -0.01
- Stochastic Oscillator
- RVNC 78.01
- PFN 42.86
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
About PFN PIMCO Income Strategy Fund II
PIMCO Income Strategy Fund II is a closed-ended fixed income mutual fund. The company's primary investment objective is to seek high current income, consistent with the preservation of capital. The fund invests in a range of securities, such as corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, municipal bonds and notes, short-term instruments, sovereign Issues, preferred Securities and others.